Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Bukowski

Showing results (91-100 of 167) with videos related to

Pageof 17
Sort By:
Human Pathology|March 1, 1980
Acute nonlymphocytic leukemia in patients receiving chemotherapy for nonmalignant diseasesK Sheibani, R M Bukowski, R R Tubbs, et al.
Cancer|January 15, 1993
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group studyR M Bukowski, T R Fleming, J S Macdonald, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12J Ulchaker, J Panuto, P Rayman, et al.
Cancer|July 15, 1982
Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinomaR M Bukowski, L P Schacter, C W Groppe, et al.
Cleveland Clinic Quarterly|January 1, 1978
Case report. Aplastic anemia. Effect of antithymocyte globulin on erythroid colony formationS A Hamburger, J H Finke, D L Laffay, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1981
Therapy of thrombotic thrombocytopenic purpura: an overviewR M Bukowski, J S Hewlett, R R Reimer, et al.
The Journal of Urology|May 1, 1977
Immunotherapy of disseminated renal cell carcinoma with transfer factorJ E Montie, R M Bukowski, S H Deodhar, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of platinum and mitoxantrone in metastatic prostate cancer: a Southwest Oncology Group StudyC K Osborne, B A Blumenstein, E D Crawford, et al.
Investigational New Drugs|January 1, 1984
Chlorozotocin: results in colorectal carcinoma treated with high and low doses. A Southwest Oncology Group studyC D Haas, J D McCracken, C B Vaughn, et al.
International Journal of Cancer|August 1, 1994
T lymphocytes infiltrating renal cell carcinoma have a reduced expression of transferrin receptorS Kudoh, J Stanley, M G Edinger, et al.
Pageof 17

Showing results (91-100 of 167) with videos related to

Sort By:
Pageof 17
Human Pathology|March 1, 1980
Acute nonlymphocytic leukemia in patients receiving chemotherapy for nonmalignant diseasesK Sheibani, R M Bukowski, R R Tubbs, et al.
Cancer|January 15, 1993
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group studyR M Bukowski, T R Fleming, J S Macdonald, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12J Ulchaker, J Panuto, P Rayman, et al.
Cancer|July 15, 1982
Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinomaR M Bukowski, L P Schacter, C W Groppe, et al.
Cleveland Clinic Quarterly|January 1, 1978
Case report. Aplastic anemia. Effect of antithymocyte globulin on erythroid colony formationS A Hamburger, J H Finke, D L Laffay, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1981
Therapy of thrombotic thrombocytopenic purpura: an overviewR M Bukowski, J S Hewlett, R R Reimer, et al.
The Journal of Urology|May 1, 1977
Immunotherapy of disseminated renal cell carcinoma with transfer factorJ E Montie, R M Bukowski, S H Deodhar, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of platinum and mitoxantrone in metastatic prostate cancer: a Southwest Oncology Group StudyC K Osborne, B A Blumenstein, E D Crawford, et al.
Investigational New Drugs|January 1, 1984
Chlorozotocin: results in colorectal carcinoma treated with high and low doses. A Southwest Oncology Group studyC D Haas, J D McCracken, C B Vaughn, et al.
International Journal of Cancer|August 1, 1994
T lymphocytes infiltrating renal cell carcinoma have a reduced expression of transferrin receptorS Kudoh, J Stanley, M G Edinger, et al.
Pageof 17